Patents by Inventor Weimin Qi

Weimin Qi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-p40 antibodies systems and methods
    Patent number: 9428576
    Abstract: The present invention is related to the anti-p40 antibodies, kits, cocktails, and use of anti-p40 antibodies for detection of cancer.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: August 30, 2016
    Assignee: Biocare Medical, LLC
    Inventors: David Tacha, Weimin Qi
  • Anti-uroplakin II antibodies systems and methods
    Patent number: 9429577
    Abstract: The present invention is related to the anti-Uroplakin II antibodies, kits, cocktails, and use of anti-Uroplakin II antibodies for detection of cancer.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: August 30, 2016
    Assignee: Biocare Medical, LLC
    Inventors: Weimin Qi, David Tacha
  • Systems and methods for anti-PAX8 antibodies
    Patent number: 9417243
    Abstract: The present invention is related to the anti-PAX8 antibodies, kits, cocktails, and use of anti-PAX8 antibodies for detection of cancer.
    Type: Grant
    Filed: October 6, 2014
    Date of Patent: August 16, 2016
    Assignee: Biocare Medical, LLC
    Inventors: Weimin Qi, David Tacha
  • Anti-SOX10 Antibody Systems and Methods
    Publication number: 20160216269
    Abstract: The present invention is related to the anti-SOX10 antibodies, kits, cocktails, and use of anti-SOX10 antibodies for detection of cancer.
    Type: Application
    Filed: October 3, 2014
    Publication date: July 28, 2016
    Inventors: David Tacha, Weimin Qi
  • Anti-p40 Antibodies Systems and Methods
    Publication number: 20160009795
    Abstract: The present invention is related to the anti-p40 antibodies, kits, cocktails, and use of anti-p40 antibodies for detection of cancer.
    Type: Application
    Filed: August 28, 2015
    Publication date: January 14, 2016
    Inventors: David Tacha, Weimin Qi
  • Anti-Uroplakin II Antibodies Systems and Methods
    Publication number: 20150247861
    Abstract: The present invention is related to the anti-Uroplakin II antibodies, kits, cocktails, and use of anti-Uroplakin II antibodies for detection of cancer.
    Type: Application
    Filed: September 26, 2013
    Publication date: September 3, 2015
    Inventors: Weimin Qi, David Tacha
  • Systems and Methods for Anti-PAX8 Antibodies
    Publication number: 20150056635
    Abstract: The present invention is related to the anti-PAX8 antibodies, kits, cocktails, and use of anti-PAX8 antibodies for detection of cancer.
    Type: Application
    Filed: October 6, 2014
    Publication date: February 26, 2015
    Inventors: Weimin Qi, David Tacha
  • Systems and methods for anti-PAX8 antibodies
    Patent number: 8852592
    Abstract: The present invention is related to the anti-PAX8 antibodies, kits, cocktails, and use of anti-PAX8 antibodies for detection of cancer.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: October 7, 2014
    Assignee: Biocare Medical, LLC
    Inventors: Weimin Qi, David Tacha
  • Systems and Methods for Anti-PAX8 Antibodies
    Publication number: 20140004542
    Abstract: The present invention is related to the anti-PAX8 antibodies, kits, cocktails, and use of anti-PAX8 antibodies for detection of cancer.
    Type: Application
    Filed: May 10, 2012
    Publication date: January 2, 2014
    Applicant: BIOCARE MEDICAL, LLC
    Inventors: Weimin Qi, David Tacha
  • P-cadherin as a target for anti-cancer therapy
    Publication number: 20060039915
    Abstract: Method of treating or diagnosing cancers involving P-cadherin expression are provided using ligands that target P-cadherin, especially human anti-P-cadherin antibodies. Also provided are screens for identifying anti-P-cadherin antibodies having therapeutic activity.
    Type: Application
    Filed: November 1, 2005
    Publication date: February 23, 2006
    Applicant: Chiron Corporation
    Inventors: Christoph Reinhard, Julie Klinger, Ann Jefferson, Jaime Escobedo, Fillipo Randazzo, Jill Winter, Robert Goodson, Weimin Qi
  • Therapeutic binding agents against MUC-1 antigen and methods for their use
    Publication number: 20050048059
    Abstract: The invention provides therapeutic compositions comprising binding agents that specifically bind to tumor-associated MUC-1 and reduce, reverse or prevent their effects in cancer. More particularly, the invention provides therapeutic compositions that comprise a binding agent that can specifically bind to an epitope that comprises both peptide and carbohydrate on such tumor-associated MUC-1. The invention further provides methods for the use of such therapeutic compositions in the treatment of cancer.
    Type: Application
    Filed: January 7, 2004
    Publication date: March 3, 2005
    Applicant: AltaRex Corp.
    Inventors: Ragupathy Madiyalakan, Weimin Qi, Birgit Schultes
  • P-cadherin as a target for anti-cancer therapy
    Publication number: 20030194406
    Abstract: Method of treating or diagnosing cancers involving P-cadherin expression are provided using ligands that target P-cadherin, especially human anti-P-cadherin antibodies.
    Type: Application
    Filed: May 31, 2002
    Publication date: October 16, 2003
    Applicant: CHIRON Corporation
    Inventors: Christoph Reinhard, Julie Klinger, Ann Jefferson, Jaime Escobedo, Fillipo Randazzo, Jill Winter, Robert Goodson, Weimin Qi